Page 10 - Vitamin D and Cancer
P. 10

Contributors
















            Tadayuki Akagi Ph.D.
            Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA
            School of Medicine, Los Angeles, CA, USA
            Christine M. Barnett M.D.
            Division of Hematology and Medical Oncology, Knight Cancer Institute,
            Oregon Health & Science University, CH-14R, 3303 SW Bond Ave, Portland,
            OR 97239, USA
            Tomasz M. Beer M.D.
            Division of Hematology & Medical Oncology, Oregon Health & Science
            University, Knight Cancer Institute 3303 SN Bond Avenue, CH14R Portland,
            OR 97239–3098, USA
            Moray J. Campbell Ph.D.
            Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute,
            Elm & Carlton Streets, Buffalo, NY 14263, USA
            Florence SG. Cheung M.D., Ph.D.
            Plunkett Chair of Molecular Biology (Medicine), Bosch Institute, The University
            of Sydney, Camperdown, NSW 2006, Australia
            Heidi S. Cross Ph.D.
            Department of Pathophysiology, Medical University of Vienna,
            Waehringer Guertel 18–20, A-1090 Vienna, Austria
            Marwan Fakih M.D.
            Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA

            David Feldman M.D.
            Department of Medicine, Division of Endocrinology, Stanford University School
            of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305–5103, USA
            Barbara A. Foster Ph.D.
            Pharmacology & Therapeutics, Roswell Park Cancer Institute, Elm & Carlton
            Streets, Buffalo, NY 14263, USA



                                                                             ix
   5   6   7   8   9   10   11   12   13   14   15